VA Launches GLP-1 Trial for 600 Veterans With Alcohol Use Disorder and Diabetes
Updated
Updated · KOMO News · Jul 31
VA Launches GLP-1 Trial for 600 Veterans With Alcohol Use Disorder and Diabetes
3 articles · Updated · KOMO News · Jul 31
Summary
600 veterans ages 18 to 80 will be enrolled at 18 VA medical centers in a new trial testing whether GLP-1 treatment can reduce alcohol consumption in veterans who also have diabetes.
Recruitment began July 28, and researchers will track changes in drinking, overall health and quality of life after participants receive the injections.
VA said prior use of GLP-1 drugs has been linked to lower emergency-room visits and potential benefits for substance-use disorders, prompting the study.
The trial, called Cessation or Reduction of Alcohol Consumption in Veterans, extends VA research into whether diabetes drugs such as semaglutide could broaden treatment options for the more than 400,000 veterans affected by AUD.